155 related articles for article (PubMed ID: 31368183)
1. Psychosis of Alzheimer's disease: Neuropsychological and neuroimaging longitudinal study.
D'Antonio F; Di Vita A; Zazzaro G; Brusà E; Trebbastoni A; Campanelli A; Ferracuti S; de Lena C; Guariglia C; Boccia M
Int J Geriatr Psychiatry; 2019 Nov; 34(11):1689-1697. PubMed ID: 31368183
[TBL] [Abstract][Full Text] [Related]
2. Grey matter atrophy in mild cognitive impairment / early Alzheimer disease associated with delusions: a voxel-based morphometry study.
Ting WK; Fischer CE; Millikin CP; Ismail Z; Chow TW; Schweizer TA
Curr Alzheimer Res; 2015; 12(2):165-72. PubMed ID: 25654501
[TBL] [Abstract][Full Text] [Related]
3. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
[TBL] [Abstract][Full Text] [Related]
4. Decreased gray matter volume is associated with the subtypes of psychotic symptoms in patients with antipsychotic-naïve mild or moderate Alzheimer's disease: A voxel-based morphometry study.
Lee YM; Chung YI; Park JM; Lee BD; Moon E; Jeong HJ; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH; Kim EJ
Psychiatry Res Neuroimaging; 2016 Mar; 249():45-51. PubMed ID: 27000306
[TBL] [Abstract][Full Text] [Related]
5. Grey Matter Loss at Different Stages of Cognitive Decline: A Role for the Thalamus in Developing Alzheimer's Disease.
van de Mortel LA; Thomas RM; van Wingen GA;
J Alzheimers Dis; 2021; 83(2):705-720. PubMed ID: 34366336
[TBL] [Abstract][Full Text] [Related]
6. Gray matter atrophy in patients with mild cognitive impairment/Alzheimer's disease over the course of developing delusions.
Fischer CE; Ting WK; Millikin CP; Ismail Z; Schweizer TA;
Int J Geriatr Psychiatry; 2016 Jan; 31(1):76-82. PubMed ID: 25821062
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal Fluid C-C Motif Chemokine Ligand 2 Correlates with Brain Atrophy and Cognitive Impairment in Alzheimer's Disease.
Kimura A; Yoshikura N; Hayashi Y; Inuzuka T
J Alzheimers Dis; 2018; 61(2):581-588. PubMed ID: 29171996
[TBL] [Abstract][Full Text] [Related]
8. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volumetric study.
Barber R; McKeith IG; Ballard C; Gholkar A; O'Brien JT
Dement Geriatr Cogn Disord; 2001; 12(3):198-205. PubMed ID: 11244213
[TBL] [Abstract][Full Text] [Related]
9. Comparison of regional gray matter volume abnormalities in Alzheimer׳s disease and late life depression with hippocampal atrophy using VSRAD analysis: a voxel-based morphometry study.
Shimoda K; Kimura M; Yokota M; Okubo Y
Psychiatry Res; 2015 Apr; 232(1):71-5. PubMed ID: 25773003
[TBL] [Abstract][Full Text] [Related]
10. Right hippocampus atrophy is independently associated with Alzheimer's disease with psychosis.
Lee K; Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Kim SY; Chung YI; Kim JH
Psychogeriatrics; 2019 Mar; 19(2):105-110. PubMed ID: 30430708
[TBL] [Abstract][Full Text] [Related]
11. Gray matter volumes and treatment response of psychotic symptoms to risperidone in antipsychotic-naïve Alzheimer's disease patients.
Lee YM; Park JM; Lee BD; Moon E; Jeong HJ; Chung YI; Kim JH; Kim HJ; Mun CW; Kim TH; Kim YH
J Clin Psychiatry; 2016 Jan; 77(1):e8-13. PubMed ID: 26845282
[TBL] [Abstract][Full Text] [Related]
12. Distinct white matter injury associated with medial temporal lobe atrophy in Alzheimer's versus semantic dementia.
Bejanin A; Desgranges B; La Joie R; Landeau B; Perrotin A; Mézenge F; Belliard S; de La Sayette V; Eustache F; Chételat G
Hum Brain Mapp; 2017 Apr; 38(4):1791-1800. PubMed ID: 27981671
[TBL] [Abstract][Full Text] [Related]
13. Modeling grey matter atrophy as a function of time, aging or cognitive decline show different anatomical patterns in Alzheimer's disease.
Dicks E; Vermunt L; van der Flier WM; Visser PJ; Barkhof F; Scheltens P; Tijms BM;
Neuroimage Clin; 2019; 22():101786. PubMed ID: 30921610
[TBL] [Abstract][Full Text] [Related]
14. Lower cerebral blood flow is associated with faster cognitive decline in Alzheimer's disease.
Benedictus MR; Leeuwis AE; Binnewijzend MA; Kuijer JP; Scheltens P; Barkhof F; van der Flier WM; Prins ND
Eur Radiol; 2017 Mar; 27(3):1169-1175. PubMed ID: 27334014
[TBL] [Abstract][Full Text] [Related]
15. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer's disease.
Convit A; de Asis J; de Leon MJ; Tarshish CY; De Santi S; Rusinek H
Neurobiol Aging; 2000; 21(1):19-26. PubMed ID: 10794844
[TBL] [Abstract][Full Text] [Related]
16. Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.
Weiler M; Agosta F; Canu E; Copetti M; Magnani G; Marcone A; Pagani E; Balthazar ML; Comi G; Falini A; Filippi M
J Alzheimers Dis; 2015; 47(4):995-1007. PubMed ID: 26401778
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease.
Phillips JS; Da Re F; Irwin DJ; McMillan CT; Vaishnavi SN; Xie SX; Lee EB; Cook PA; Gee JC; Shaw LM; Trojanowski JQ; Wolk DA; Grossman M
Brain; 2019 Jun; 142(6):1701-1722. PubMed ID: 31135048
[TBL] [Abstract][Full Text] [Related]
18. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
19. A neuroimaging approach to capture cognitive reserve: Application to Alzheimer's disease.
van Loenhoud AC; Wink AM; Groot C; Verfaillie SCJ; Twisk J; Barkhof F; van Berckel B; Scheltens P; van der Flier WM; Ossenkoppele R
Hum Brain Mapp; 2017 Sep; 38(9):4703-4715. PubMed ID: 28631336
[TBL] [Abstract][Full Text] [Related]
20. Changes of brain structure in Parkinson's disease patients with mild cognitive impairment analyzed via VBM technology.
Gao Y; Nie K; Huang B; Mei M; Guo M; Xie S; Huang Z; Wang L; Zhao J; Zhang Y; Wang L
Neurosci Lett; 2017 Sep; 658():121-132. PubMed ID: 28823894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
